Close

GNVC Balance Sheet

Click line-items for a historical chart and %
Cash and cash equivalents 8.67M
Short-term investments 19.81M
Accounts receivable 2.7M
Prepaid expenses and other 352K
Total current assets 31.53M
Property and equipment, net 729K
Other assets 88K
Total assets 32.35M
Accounts payable 1.26M
Accrued clinical trial expenses 120K
Accrued other expenses 1.72M
Unearned revenue 597K
Total current liabilities 3.69M
Unearned revenue 0
Total liabilities 3.69M
Preferred stock, $0.001 par value, 5,000 shares authorized; none issued and outstanding in 2011 and 2010 0
Common stock, $0.001 par value; 30,000 shares authorized; 12,918 and 12,908 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively 13K
Additional paid-in capital 277.81M
Accumulated other comprehensive income 44K
Accumulated deficit -249.2M
Total stockholders' equity 28.66M
Total liabilities and stockholders' equity 32.35M

Entities mentioned with GNVC

View All Entities